非MRI兼容心脏植入电子装置患者MRI的安全性与临床影响:PROMeNADe注册研究
PROMeNADe前瞻性注册研究纳入532例非MRI兼容心脏植入电子装置患者,共完成608次MRI检查(其中心脏MRI 61次),每次检查前后均行装置程控。结果显示无患者或装置相关并发症,且MRI改变了25%的疑似诊断、26%的疑似预后和42%的预定治疗。
要点
- 非MRI兼容心脏装置患者行MRI(含胸部MRI)未发生患者或装置相关并发症。
- 起搏器依赖患者(占全部MRI 27%)采用异步起搏、ICD患者检查时关闭心动过速治疗。
- MRI改变了25%的疑似诊断、26%的疑似预后及42%的预定药物或手术治疗。
关键影像表现/征象
- 心脏装置包括起搏器(46%)、ICD(30%)、CRT起搏器(4%)、CRT除颤器(17%)及废弃导线(2%)。
- 起搏器依赖患者占所有MRI检查的27%。
- 无患者相关或装置相关并发症发生。
临床应用与阅片要点
- 起搏器依赖患者行MRI时采用异步起搏模式。
- ICD患者行MRI时关闭心动过速治疗。
- 每次MRI前后均行装置程控,并由电生理护士监测血流动力学或节律异常。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore the safety and clinical utility of MRI in participants with non-MRI-conditional cardiac implantable electronic devices, by establishing the Patient Registry of Magnetic Resonance Imaging in Non-Approved DEvices (PROMeNADe).
MATERIALS AND METHODS: From September 2015 to June 2019, 532 participants (211 women) with a mean age of 69 years ± 14 (standard deviation) were enrolled prospectively in the PROMeNADe registry (ClinicalTrials.gov identifier: NCT03081364) and underwent a total of 608 MRI examinations (61 cardiac MRI examinations). All participants had device interrogations performed before and after each MRI. Pacemaker-dependent patients received asynchronous pacing. Patients with an implantable cardioverter defibrillator (ICD) had tachycardia therapies disabled during the MRI. An electrophysiology nurse monitored participants for any hemodynamic or rhythm abnormalities. Referring physicians were surveyed regarding the clinical utility of the MRI. Standard descriptive analyses included summary statistics with percentages and means.
RESULTS: Cardiac devices included pacemakers (46%), ICDs (30%), cardiac resynchronization therapy (CRT) pacemakers (4%), and CRT defibrillators (17%), as well as abandoned leads (2%). Pacemaker-dependent patients comprised 27% of all MRI examinations. There were no patient- or device-related complications. Clinical utility surveys of MRI examinations were completed by 150 physicians. According to the survey responses, these MRI examinations changed the suspected diagnosis 25% of the time and changed suspected prognosis in 26% of participants, with planned medical or surgical treatment being changed 42% of the time.
CONCLUSION: This registry demonstrates that MRI examinations, including thoracic MRI examinations, can be performed safely in patients who have non-MRI-conditional devices, in pacemaker-dependent patients with ICDs, and in patients with abandoned leads. These MRI examinations can have a substantial impact on patient care, justifying the extensive resources used to perform them.Supplemental material is available for this article.© RSNA, 2020See also the commentary by Peshock in this issue.
引用
- Gupta SK, Ya'qoub L, Wimmer AP, et al. Safety and Clinical Impact of MRI in Patients with Non-MRI-conditional Cardiac Devices. Radiol Cardiothorac Imaging. 2020. PMID: 33778621. doi:10.1148/ryct.2020200086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。